In addition, the expression of ITGB4 on ALDHhigh breast cancer and head and neck cancer cells was significantly greater than that on ALDHlow cells, proving the effects that ITGB4 targets on both bulk and CSC populations (Ruan et al., 2020). Here, ITGB4 is linked to head and neck cancer.